ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 90

$865K Total Retail Price of All Prescriptions

Rank: 8 out of 90

359 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 359 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

21% of this provider’s 359 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 4,451 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 469 257 1 1
HYDROCODONE-ACETAMINOPHEN 452 83 S3 2 10
TORSEMIDE 372 227 3 29
OMEPRAZOLE 309 174 4 15
METOPROLOL TARTRATE 299 118 5 7
SIMVASTATIN 272 152 6 12
BYSTOLIC 267 148 7 41
LEVOTHYROXINE SODIUM 256 150 8 21
CRESTOR 249 111 9 44
ALLOPURINOL 241 181 10 13
FUROSEMIDE 240 147 11 2
HYDRALAZINE HCL 235 164 12 11
LISINOPRIL 230 118 13 3
SENSIPAR 180 29 14 5
PREDNISONE 178 74 15 27
CALCITRIOL 161 104 16 14
CARVEDILOL 154 82 17 6
ATORVASTATIN CALCIUM 144 61 18 23
RENVELA 137 43 19 4
DIOVAN 134 96 20 18
METOPROLOL SUCCINATE 134 69 20 40
ZOLPIDEM TARTRATE 105 43 22 30
GABAPENTIN 104 47 23 22
NEXIUM 97 45 24 38
CLONIDINE HCL 93 73 25 9
LOSARTAN POTASSIUM 90 50 26 17
CYMBALTA 88 30 27 73
MINOXIDIL 79 23 28 32
CLOPIDOGREL 77 24 29 47
TRAMADOL HCL 75 50 30 26
PROMETHAZINE HCL 72 0 R 31 61
DEXILANT 58 32 32 140
POTASSIUM CHLORIDE 58 38 32 54
WARFARIN SODIUM 57 0 34 34
CEPHALEXIN 56 38 35 144
PRAVASTATIN SODIUM 54 41 36 20
CALCIUM ACETATE 52 16 37 8
GLIPIZIDE 52 21 37 67
TAMSULOSIN HCL 51 45 39 62
RANITIDINE HCL 50 16 40 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.